BellBrook Labs

Madison, United States Founded: 2002 • Age: 24 yrs
Specialty company engaged in drug discovery and biological research by providing screening solutions for enzymes and phenotypic assays

About BellBrook Labs

BellBrook Labs is a Healthcare company based in Madison (United States) founded in 2002. Specialty company engaged in drug discovery and biological research by providing screening solutions for enzymes and phenotypic assays. BellBrook Labs has raised $1.89 million across 36 funding rounds from investors including NIH and HHS. Its website bellbrooklabs.com draws about 10 thousand monthly visits. BellBrook Labs offers products and services including Transcreener HTS Assays, AptaFluor HTS Assays, Recombinant Enzymes, and Enzolution Assay Systems. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Cell Based Assays. Its competitors include Lucid Scientific, Kiyatec and CytoTronics; 3 of its 3 listed competitors have raised funding.

Company details

BellBrook Labs was founded in 2002 in Madison, United States, focusing on drug discovery and biological research. Enzyme screening solutions, including Transcreener for targets such as kinases, ATPases, and GTPases, are offered alongside phenotypic assays. Iuvo supports miniaturized tissue-like cell models and quantitative cell motility assays. Additional technologies for assay development and molecule screening are included in operations. Wisconsin Development Fund awards were received in 2014.

Key Metrics
  • Total Equity Funding
    $1.89M (USD)

    in 36 rounds

  • Latest Funding Round
    $270.93K (USD), Grant

    Sep 2024

  • Investors
    NIH

    & 1 more

Products & Services of BellBrook Labs

BellBrook Labs offers a comprehensive portfolio of products and services, including Transcreener HTS Assays, AptaFluor HTS Assays, Recombinant Enzymes, and Enzolution Assay Systems.

Transcreener HTS Assays
Biochemical Assays

Detects nucleotides for enzymes like kinases and ATPases in drug screening.

AptaFluor HTS Assays
Methyltransferase Assays

Assays for methyltransferase activity using SAM in biochemical research.

Recombinant Enzymes
Biotech Products

Purified human enzymes for HTS validation and inhibitor studies.

Enzolution Assay Systems
Assay Solutions

Complete systems for biochemical assays in drug discovery applications.

Apps and channels of BellBrook Labs

its YouTube channel BellBrook Labs has 32 subscribers and 25 videos.

BellBrook Labs
YouTube 32 subscribers 25 videos Science & Technology
Open channel

Videos from BellBrook Labs

The most watched videos on BellBrook Labs's YouTube channel, BellBrook Labs (32 subscribers). Click a video to play it here.

Complete Biochemical Assay Solutions for Your Toughest Enzyme Targets
13.4K views
How Do Transcreener HTS Biochemical Assays Work?
3.6K views
Why Does Sensitivity Matter for HTS Assays?
3.2K views
Finding the Right Biochemical Assay for HTS and Lead Discovery
2.5K views

More on BellBrook Labs.

Funding Insights of BellBrook Labs

BellBrook Labs has successfully raised a total of $1.89M across 36 strategic funding rounds. The most recent funding activity was a Grant round of $270.93 thousand completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.89M
  • Total Rounds 36
  • Last Round Grant β€” $270,929
  • First Round $1.5M

    (Apr 2005)

  • Investors Count 2

Latest 10 of 36 funding rounds of BellBrook Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2024$270,929Grant––
Aug 2021$390,500Grant––
Sep 2020$300,000Grant––
Jun 2019$1.82MGrant––
Nov 2018$200,000Seed––
–
May 2017$1.63MGrant––
Sep 2016$353,332Grant––
Sep 2016$234,936Grant––
Jun 2015$225,000Grant––
Apr 2015$224,999Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in BellBrook Labs

BellBrook Labs has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
Drug discovery services are provided to the biopharma sector.
1887nih.govUnited States
Premium access

Investor details for BellBrook Labs

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of BellBrook Labs

2 people are tracked at BellBrook Labs (2 in leadership).

NameRoleGroup
Robert Lowery
President & CEOLeadership
Traci Pretsch
Chief Financial OfficerLeadership
Premium access

Complete people profiles for BellBrook Labs

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of BellBrook Labs

3 dated milestones of BellBrook Labs across 22 years, from founding to its latest funding, stage changes and deals.

  1. Founded BellBrook Labs is founded.
  2. Funding First funding round of $1.5M.
  3. Funding Latest funding round, Grant, of $271K.

Competitors of BellBrook Labs

BellBrook Labs has 3 listed competitors in our database, 3 of them funded. They include Lucid Scientific, Kiyatec and CytoTronics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lucidsci.com2012Atlanta, United States$12.73M
Real-time cell analyzers are developed for oxygen consumption monitoring.
kiyatec.com2005Pendleton, United States$29.49M
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
cytotronics.com2015Boston, United States$22.75M22
Cell-based assays for drug discovery are developed via CMOS platform.
Premium access

Detailed competitors of BellBrook Labs

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of BellBrook Labs

The website of BellBrook Labs (bellbrooklabs.com) receives about 10K visits a month.

  • Monthly visits
    10K

    ▲ 5.5% vs previous month

Similar websites

Websites whose visitors overlap most with BellBrook Labs. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
microbialcell.com
microbialcell.com
100%
#1,399,822–
bdbiosciences.com
86%
331.8K#154,504View details
fibercellsystems.com
86%
3.6K#5,013,756View details
gentaur.com
gentaur.com
86%
#2,063,864–
sbhsciences.com
86%
2.5K#7,113,470View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 26 similar websites and full traffic analytics for BellBrook Labs

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 26 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as BellBrook Labs (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about BellBrook Labs

BellBrook Labs was founded in 2002 and raised its 1st funding round 3 years after it was founded.

BellBrook Labs is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.

BellBrook Labs is a funded company, having raised a total of $1.89M across 36 funding rounds to date. The company's 1st funding round was a Grant of $225K, raised on Apr 2005.

BellBrook Labs was founded in 2002 in Madison, United States, focusing on drug discovery and biological research. Enzyme screening solutions, including Transcreener for targets such as kinases, ATPases, and GTPases, are offered alongside phenotypic assays. Iuvo supports miniaturized tissue-like cell models and quantitative cell motility assays. Additional technologies for assay development and molecule screening are included in operations. Wisconsin Development Fund awards were received in 2014.

BellBrook Labs's top competitors include CytoTronics, Kiyatec and Lucid Scientific.

BellBrook Labs offers Transcreener HTS Assays, AptaFluor HTS Assays, Recombinant Enzymes, and Enzolution Assay Systems.

BellBrook Labs has 2 investors. Key investors include NIH, and HHS.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available